AMA Adopts Resolution Introduced by The Endocrine Society Calling for FDA Oversight of Bioidentical HormonesThe American Medical Association's (AMA) House of Delegates unanimously and enthusiastically passed a resolution introduced by The Endocrine Society and other concerned organizations urging the U.S. Food and Drug Administration (FDA) to increase its oversight and regulation of so-called bioidentical hormones.
[...]
Since the final hormone formulations of most compounding pharmacies are not subject to FDA monitoring for dose, purity, safety, or efficacy there may be additional, and at this point unknown, risks associated with them. Post- market surveys of such hormone preparations have uncovered inconsistencies in dose and quality.
-------------
Please read the entire article before replying.